CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- PRRN14A Other PRRN14A
- ARS Other Annual Report to Security Holders
- DEFC14A Other DEFC14A
- PRER14A Other PRER14A
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- 4/A Grant or award Chief Financial Officer acquired 175,000 shares (grant or award)
- 4/A Grant or award Executive President acquired 100,000 shares (grant or award)
- 4/A Grant or award Chief Accounting Officer acquired 75,000 shares (grant or award)
- DFAN14A Other Proxy Soliciting Materials
- PREC14A Other PREC14A
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- PREC14A Other PREC14A
- 8-K Event Executive or director change
- 4 Grant or award Chief Legal Officer acquired 200,000 shares (grant or award)
Page 17 of 26 · 506 filings